Business Information
The group's principal activity is to develop, manufacture and market immunodiagnostic systems and immunochemistry kits. The group's products are used by hospital, veterinary, research and forensic laboratories and doctors' offices to obtain precise rapid identification and measurement of hormones, drugs, viruses, bacteria and other substances present in body fluids and tissues. The immulite products uses patented solid-phase wash technology and chemiluminescent detection method, which together are capable of measuring at exceptionally low concentrations, tsh and psa - key tests related to thyroid disorders and prostate cancer, respectively. Radioimmunoassay products are used for allergy testing, which uses liquid-allergen technology in tube and microplate formats. The group has manufacturing facilities in the United States, the United Kingdom, Germany and China.
|
|
Name |
Title
|
Email
|
| Jeffrey Fox | VP - Investment Accounting | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 110,797,960 | 3,848,270 | | 2005 | 90,896,136 | 2,708,390 | | 2004 | 92,688,428 | 4,198,706
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
